A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety, Tolerability and Efficacy of PrimeC in Subjects With ALS

Lawson Health Research Institute, London, Ontario, Canada

Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

IRCCS Istituti clinici Maugeri, Milan, Italy

A.O.U. Citta della Salute e della Scienza di Torino, Torino, Italy